Loading...
Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant neoplasms, further subcategorized in over 20 histological subtypes. For the most part, treatment for advanced disease is guided by morphology. SGC in general respond poorly to standard chemotherapy, with short durabi...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7649804/ https://ncbi.nlm.nih.gov/pubmed/33194707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.580141 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|